Literature DB >> 21387165

Multidisciplinary treatment with chemotherapy, targeted drug, and high-intensity focused ultrasound in advanced pancreatic carcinoma.

Ying Yuan1, Hong Shen, Xiao-Ye Hu, Fei-Ying Gu, Mo-Dan Li, Xian Zhong.   

Abstract

This study reports a case of an advanced pancreatic cancer patient with liver metastasis who was treated with a combination of chemotherapy, targeted drugs, and high-intensity focused ultrasound (HIFU). The abdominal pain was successfully relieved after the HIFU therapy. The patient had an 18-month survival with satisfactory quality of life. Large-scale randomized clinical trials are necessary to evaluate the long-term efficacy of HIFU treatment with or without chemotherapy and/or targeted drug therapy for pancreatic carcinoma.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21387165     DOI： 10.1007/s12032-011-9892-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  10 in total

1.  High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma.

Authors:  Xiao Wang; Jingzhong Sun
Journal:  Chin Med J (Engl)       Date:  2002-09       Impact factor: 2.628

2.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Authors:  H A Burris; M J Moore; J Andersen; M R Green; M L Rothenberg; M R Modiano; M C Cripps; R K Portenoy; A M Storniolo; P Tarassoff; R Nelson; F A Dorr; C D Stephens; D D Von Hoff
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

3.  Erlotinib in previously treated non-small-cell lung cancer.

Authors:  Frances A Shepherd; José Rodrigues Pereira; Tudor Ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

4.  Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  Malcolm J Moore; David Goldstein; John Hamm; Arie Figer; Joel R Hecht; Steven Gallinger; Heather J Au; Pawel Murawa; David Walde; Robert A Wolff; Daniel Campos; Robert Lim; Keyue Ding; Gary Clark; Theodora Voskoglou-Nomikos; Mieke Ptasynski; Wendy Parulekar
Journal:  J Clin Oncol       Date:  2007-04-23       Impact factor: 44.544

5.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Authors:  David Cunningham; Yves Humblet; Salvatore Siena; David Khayat; Harry Bleiberg; Armando Santoro; Danny Bets; Matthias Mueser; Andreas Harstrick; Chris Verslype; Ian Chau; Eric Van Cutsem
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

6.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

7.  Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

Authors:  Masahiro Fukuoka; Seiji Yano; Giuseppe Giaccone; Tomohide Tamura; Kazuhiko Nakagawa; Jean-Yves Douillard; Yutaka Nishiwaki; Johan Vansteenkiste; Shinzoh Kudoh; Danny Rischin; Richard Eek; Takeshi Horai; Kazumasa Noda; Ichiro Takata; Egbert Smit; Steven Averbuch; Angela Macleod; Andrea Feyereislova; Rui-Ping Dong; José Baselga
Journal:  J Clin Oncol       Date:  2003-05-14       Impact factor: 44.544

Review 8.  Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.

Authors:  Burton L Eisenberg; Ian Judson
Journal:  Ann Surg Oncol       Date:  2004-05       Impact factor: 5.344

9.  Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer.

Authors:  Hong Zhao; Guowang Yang; Daoyuan Wang; Xiangrong Yu; Yu Zhang; Junqiu Zhu; Yongle Ji; Baoliang Zhong; Wenshuo Zhao; Zhong Yang; Fahad Aziz
Journal:  Anticancer Drugs       Date:  2010-04       Impact factor: 2.248

10.  Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Jamie Ritchey; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860
  10 in total
  5 in total

Review 1.  High-intensity focused ultrasound therapy for pancreatic cancer.

Authors:  Atsushi Sofuni; Yasutsugu Asai; Shuntaro Mukai; Kenjiro Yamamoto; Takao Itoi
Journal:  J Med Ultrason (2001)       Date:  2022-05-12       Impact factor: 1.314

Review 2.  High intensity focused ultrasound (HIFU) applied to hepato-bilio-pancreatic and the digestive system-current state of the art and future perspectives.

Authors:  Michele Diana; Luigi Schiraldi; Yu-Yin Liu; Riccardo Memeo; Didier Mutter; Patrick Pessaux; Jacques Marescaux
Journal:  Hepatobiliary Surg Nutr       Date:  2016-08       Impact factor: 7.293

3.  A meta-analysis of palliative treatment of pancreatic cancer with high intensity focused ultrasound.

Authors:  Susan Dababou; Cristina Marrocchio; Jarrett Rosenberg; Rachelle Bitton; Kim Butts Pauly; Alessandro Napoli; Joo Ha Hwang; Pejman Ghanouni
Journal:  J Ther Ultrasound       Date:  2017-04-01

4.  Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy.

Authors:  Atsushi Sofuni; Yasutsugu Asai; Takayoshi Tsuchiya; Kentaro Ishii; Reina Tanaka; Ryosuke Tonozuka; Mitsuyoshi Honjo; Shuntaro Mukai; Kazumasa Nagai; Kenjiro Yamamoto; Yukitoshi Matsunami; Takashi Kurosawa; Hiroyuki Kojima; Toshihiro Homma; Hirohito Minami; Ryosuke Nakatsubo; Noriyuki Hirakawa; Hideaki Miyazawa; Yuichi Nagakawa; Akihiko Tsuchida; Takao Itoi
Journal:  Curr Oncol       Date:  2021-11-20       Impact factor: 3.677

Review 5.  High-intensity focused ultrasound treatment for advanced pancreatic cancer.

Authors:  Yufeng Zhou
Journal:  Gastroenterol Res Pract       Date:  2014-06-26       Impact factor: 2.260
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.